英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

beforehand    音标拼音: [bɪf'ɔrh,ænd]
ad. 事先,提前

事先,提前

beforehand
adv 1: ahead of time; in anticipation; "when you pay ahead (or
in advance) you receive a discount"; "We like to plan
ahead"; "should have made reservations beforehand" [synonym:
{ahead}, {in advance}, {beforehand}]
adj 1: being ahead of time or need; "gave advance warning"; "was
beforehand with her report" [synonym: {advance(a)},
{beforehand(p)}]

Beforehand \Be*fore"hand`\, adv. [Before hand.]
[1913 Webster]
1. In a state of anticipation ore preoccupation; in advance;
-- often followed by with.
[1913 Webster]

Agricola . . . resolves to be beforehand with the
danger. --Milton.
[1913 Webster]

The last cited author has been beforehand with me.
--Addison.
[1913 Webster]

2. By way of preparation, or preliminary; previously;
aforetime.
[1913 Webster]

They may be taught beforehand the skill of speaking.
--Hooker.
[1913 Webster]


Beforehand \Be*fore"hand`\, a.
In comfortable circumstances as regards property; forehanded.
[1913 Webster]

Rich and much beforehand. --Bacon.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
Beforehand查看　Beforehand　在百度字典中的解释百度英翻中〔查看〕
Beforehand查看　Beforehand　在Google字典中的解释Google英翻中〔查看〕
Beforehand查看　Beforehand　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
  • Treating Squamous Cell Carcinoma | Squamous Cell Cancer . . .
    Treating advanced squamous cell cancers Different types of treatments might be used for SCCs that have spread beyond the skin Lymph node dissection: Removing regional (nearby) lymph nodes might be recommended for some SCCs that are very large or have grown deeply into the skin, as well as if the lymph nodes feel enlarged and or hard
  • Cemiplimab-rwlc - NCI - National Cancer Institute
    Cemiplimab-rwlc is a type of drug called an immune checkpoint inhibitor (a type of immunotherapy) It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells It works by keeping cancer cells from suppressing the immune system This allows the immune system to attack and kill the cancer cells
  • LIBTAYO® Full Prescribing Information | Regeneron
    1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum-based chemotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
  • label - accessdata. fda. gov
    1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
  • Libtayo (cemiplimab) dosing, indications, interactions . . .
    Medscape - Cutaneous squamous cell carcinoma and basal cell carcinoma dosing for Libtayo (cemiplimab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost information
  • Cemiplimab (Libtayo®) - ChemoExperts
    Treatment Name: Cemiplimab (Libtayo®) Cemiplimab (Libtayo®) is an Immunotherapy Regimen for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC) How does cemiplimab work? Cemiplimab is designed to block the signals that tumor cells use to suppress the immune system allowing the immune system to attack the lung cancer cells Goals of therapy:
  • Patient Resources for LIBTAYO® (cemiplimab-rwlc) | Advanced NSCLC
    LIBTAYO resources Get more information about LIBTAYO and how it may be an appropriate treatment option for your advanced NSCLC
  • Cemiplimab (Libtayo Regeneron) - Guidelines+ Monographs
    Libtayo is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC), locally advanced or metastatic basal cell carcinoma (laBCC or mBCC), and non-small cell lung cancer (NSCLC) It was initially approved in 2018
  • For patients with a type of skin cancer called basal cell . . .
    What is LIBTAYO? LIBTAYO (Lib-TIE-oh) is a prescription medicine used to treat people with a type of skin cancer called basal cell carcinoma that cannot be removed by surgery (locally advanced BCC) and have received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with an HHI





中文字典-英文字典  2005-2009